tiprankstipranks
Trending News
More News >
EC Healthcare (HK:2138)
:2138
Hong Kong Market
Advertisement

EC Healthcare (2138) Ratios

Compare
1 Followers

EC Healthcare Ratios

HK:2138's free cash flow for Q2 2025 was HK$0.33. For the 2025 fiscal year, HK:2138's free cash flow was decreased by HK$ and operating cash flow was HK$0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.00 0.92 0.92 0.78 1.01
Quick Ratio
0.92 0.85 0.85 0.72 0.93
Cash Ratio
0.53 0.39 0.39 0.42 0.64
Solvency Ratio
0.10 0.20 0.20 0.21 0.25
Operating Cash Flow Ratio
0.42 0.48 0.48 0.36 0.44
Short-Term Operating Cash Flow Coverage
1.56 5.03 5.03 6.00 0.00
Net Current Asset Value
HK$ -940.97MHK$ -1.65BHK$ -1.65BHK$ -1.84BHK$ -1.14B
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.30 0.30 0.28 0.19
Debt-to-Equity Ratio
0.75 0.82 0.82 0.83 0.50
Debt-to-Capital Ratio
0.43 0.45 0.45 0.45 0.33
Long-Term Debt-to-Capital Ratio
0.14 0.29 0.29 0.25 0.11
Financial Leverage Ratio
2.80 2.74 2.74 2.97 2.58
Debt Service Coverage Ratio
0.63 3.12 3.10 4.35 14.32
Interest Coverage Ratio
3.43 1.08 1.84 1.76 6.27
Debt to Market Cap
0.11 0.60 0.60 0.10 0.02
Interest Debt Per Share
1.24 1.44 1.44 1.36 0.87
Net Debt to EBITDA
0.79 1.41 1.42 1.05 0.09
Profitability Margins
Gross Profit Margin
32.38%84.18%16.74%17.41%25.79%
EBIT Margin
4.54%2.80%2.80%5.16%12.68%
EBITDA Margin
10.33%17.65%17.52%20.19%27.65%
Operating Profit Margin
10.13%2.59%4.42%3.25%11.34%
Pretax Profit Margin
0.92%0.40%0.40%3.20%11.03%
Net Profit Margin
-0.28%-0.45%-0.45%1.80%6.76%
Continuous Operations Profit Margin
0.35%0.37%0.37%2.76%9.27%
Net Income Per EBT
-30.08%-112.29%-112.29%56.24%61.32%
EBT Per EBIT
9.09%15.47%9.07%98.30%97.29%
Return on Assets (ROA)
-0.23%-0.35%-0.35%1.26%4.06%
Return on Equity (ROE)
-0.60%-0.97%-0.97%3.76%10.50%
Return on Capital Employed (ROCE)
13.40%2.77%4.72%3.28%9.47%
Return on Invested Capital (ROIC)
2.62%2.34%3.90%2.27%7.30%
Return on Tangible Assets
-0.31%-0.50%-0.50%2.07%7.18%
Earnings Yield
-0.16%-1.23%-1.23%0.94%2.05%
Efficiency Ratios
Receivables Turnover
10.02 13.18 13.18 -31.06 18.78
Payables Turnover
26.48 8.21 43.24 45.66 28.81
Inventory Turnover
18.41 6.22 32.74 36.84 21.43
Fixed Asset Turnover
3.92 3.03 3.03 2.44 2.45
Asset Turnover
0.83 0.78 0.78 0.70 0.60
Working Capital Turnover Ratio
66.40 -23.17 -17.25 -21.16 133.56
Cash Conversion Cycle
42.46 41.93 30.39 -9.83 23.80
Days of Sales Outstanding
36.42 27.68 27.68 -11.75 19.44
Days of Inventory Outstanding
19.83 58.68 11.15 9.91 17.03
Days of Payables Outstanding
13.78 44.43 8.44 7.99 12.67
Operating Cycle
56.24 86.36 38.83 -1.84 36.47
Cash Flow Ratios
Operating Cash Flow Per Share
0.67 0.58 0.58 0.52 0.52
Free Cash Flow Per Share
0.53 0.45 0.45 0.17 0.30
CapEx Per Share
0.14 0.14 0.14 0.35 0.23
Free Cash Flow to Operating Cash Flow
0.80 0.77 0.77 0.32 0.57
Dividend Paid and CapEx Coverage Ratio
3.66 3.18 3.18 1.15 1.13
Capital Expenditure Coverage Ratio
4.92 4.27 4.27 1.47 2.32
Operating Cash Flow Coverage Ratio
0.59 0.43 0.43 0.40 0.64
Operating Cash Flow to Sales Ratio
0.19 0.16 0.16 0.16 0.21
Free Cash Flow Yield
8.56%34.35%34.26%2.65%3.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-642.58 -81.32 -81.32 106.27 48.68
Price-to-Sales (P/S) Ratio
1.78 0.37 0.37 1.91 3.29
Price-to-Book (P/B) Ratio
4.12 0.79 0.79 3.99 5.11
Price-to-Free Cash Flow (P/FCF) Ratio
11.69 2.92 2.92 37.80 28.01
Price-to-Operating Cash Flow Ratio
9.32 2.24 2.24 12.17 15.93
Price-to-Earnings Growth (PEG) Ratio
-16.73 0.64 0.64 -1.63 -4.62
Price-to-Fair Value
4.12 0.79 0.79 3.99 5.11
Enterprise Value Multiple
18.02 3.49 3.51 10.51 12.00
Enterprise Value
7.73B 2.59B 2.59B 8.22B 9.69B
EV to EBITDA
18.02 3.48 3.51 10.51 12.00
EV to Sales
1.86 0.61 0.62 2.12 3.32
EV to Free Cash Flow
12.22 4.90 4.91 42.00 28.23
EV to Operating Cash Flow
9.74 3.75 3.76 13.52 16.06
Tangible Book Value Per Share
0.76 0.71 0.71 0.19 0.21
Shareholders’ Equity Per Share
1.51 1.65 1.65 1.57 1.63
Tax and Other Ratios
Effective Tax Rate
0.76 0.07 0.07 0.24 0.16
Revenue Per Share
3.50 3.55 3.55 3.28 2.53
Net Income Per Share
>-0.01 -0.02 -0.02 0.06 0.17
Tax Burden
-0.30 -1.12 -1.12 0.56 0.61
Interest Burden
0.20 0.14 0.14 0.62 0.87
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.06 0.05 0.05 0.06 0.06
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.02 <0.01
Income Quality
-68.98 -36.37 40.84 8.73 3.06
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis